NRAS mutation: A potential biomarker of clinical response to immune-based therapies in metastatic melanoma (MM) Meeting Abstract


Authors: Johnson, D. B.; Lovly, C. M.; Flavin, M.; Ayers, G. D.; Zhao, Z.; Iams, W. T.; Iafrate, A. J.; Berry, E. G.; Terry, C. R.; Sullivan, R. J.; Carvajal, R. D.; Sosman, J. A.
Abstract Title: NRAS mutation: A potential biomarker of clinical response to immune-based therapies in metastatic melanoma (MM)
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419602720
PROVIDER: wos
DOI: 10.1200/jco.2013.31.15_suppl.9019
Notes: Meeting Abstract: 9019 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Richard D Carvajal
    148 Carvajal